EFFICACY OF CHLORINE DIOXIDE ON ORAL LESIONS IN ACUTE MYELOBLASTIC LEUKEMIA PATIENTS UNDERGOING CHEMOTHERAPY

##article.authors##

  • FAIZNUR RIDHO Oral Medicine Specialist Program, Faculty of Dentistry, Universitas Padjadjaran, Bandung 40132, West Java, Indonesia https://orcid.org/0000-0001-7942-0929
  • NURI FITRIASARI Oral Health Polyclinic, Oral Medicine Division, Dr. Hasan Sadikin Central General Hospital, Bandung-40161, West Java, Indonesia
  • DEWI ZAKIAWATI Department of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Bandung-40161, West Java, Indonesia

##semicolon##

Cheilitis##common.commaListSeparator## Angioedema##common.commaListSeparator## Crust##common.commaListSeparator## Cancer

##article.abstract##

Objective: The aim of this study was to describe the pharmacological management of oral lesions, particularly using chlorine dioxide agents in an acute myeloblastic leukemia (AML) patient undergoing chemotherapy.

Methods: A 9 y old girl was referred from the Department of Paediatrics at Hasan Sadikin Hospital to the Department of Oral Medicine with complaints of swelling on the lips, difficulty while eating, swallowing, and even opening the mouth. Extra oral examination showed angioedema on the lips with a prominent serosanguinolent crust. Intraoral examination revealed white plaques that could not be scrapped off in all parts of the mouth. The patient was diagnosed with AML and had received chemotherapy until the second cycle.

Results: Gauze soaked in chlorine dioxide oral rinse was applied to compress the patient's lips. Following this, 0.2% hyaluronic acid gel was also administered. In terms of intraoral treatment, chlorine dioxide was also applied by spraying it throughout the entire mouth. After one month, the lesion had completely healed, allowing the patient to open their mouth without any issues.

Conclusion: Chlorine dioxide significantly improves the oral mucosal lesions in an AML patient undergoing chemotherapy.

##submission.citations##

Thomson P. Oral cancer from prevention to intervention. UK: Cambridge Scholars Publishing; 2019.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi: 10.3322/caac.21660, PMID 33538338.

Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70-87. doi: 10.1016/j.blre.2019.04.005, PMID 31101526.

Schlosser BJ, Pirigyi M, Mirowski GW. Oral manifestations of hematologic and nutritional diseases. Otolaryngol Clin North Am. 2011;44(1):183-203. doi: 10.1016/j.otc.2010.09.007, PMID 21093629.

Lopez Valverde N, Lopez Valverde A, de Gomez-de Diego RG, Ramirez JM, Flores-Fraile J, Muriel Fernandez J. Gingival hyperplasia as an early manifestation of acute myeloid leukemia. A retrospective review. J Clin Exp Dent. 2019;11(12):e1139-42. doi: 10.4317/JCED.56214, PMID 31824594.

Busjan R, Hasenkamp J, Schmalz G, Haak R, Trümper L, Ziebolz D. Oral health status in adult patients with newly diagnosed acute leukemia. Clin Oral Investig. 2018;22(1):411-8. doi: 10.1007/s00784-017-2127-x, PMID 28536781.

Islam NM, Bhattacharyya I, Cohen DM. Common oral manifestations of systemic disease. Otolaryngol Clin North Am. 2011;44(1):161-82. doi: 10.1016/j.otc.2010.09.006, PMID 21093628.

McKenna SJ. Leukemia. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 2000;89(2):137-9. doi: 10.1067/moe.2000.102386.

McCord C, Johnson L. Oral manifestations of hematologic disease. Atlas Oral Maxillofac Surg Clin North Am. 2017;25(2):149-62. doi: 10.1016/j.cxom.2017.04.007, PMID 28778304.

Zakiawati D, Setiadhi R. Oral manifestations of acute leukemia in children: family supernatural beliefs and its contribution to the prognosis of the disease. IJMDCR. 2021;12(6):1-4. doi: 10.15713/ins.ijmdcr.176.

Guan G, Firth N. Oral manifestations as an early clinical sign of acute myeloid leukaemia: a case report. Aust Dent J. 2015;60(1):123-7. doi: 10.1111/adj.12272, PMID 25721286.

Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Burket’s oral medicine. 13th ed. Wiley-Blackwell; 2021.

Noszticzius Z, Wittmann M, Kaly Kullai K, Beregvari Z, Kiss I, Rosivall L. Chlorine dioxide is a size-selective antimicrobial agent. PLOS ONE. 2013;8(11):e79157. doi: 10.1371/journal.pone.0079157, PMID 24223899.

Pham TAV, Nguyen NTX. Efficacy of chlorine dioxide mouthwash in reducing oral malodor: a 2-week randomized, double-blind, crossover study. Clin Exp Dent Res. 2018;4(5):206-15. doi: 10.1002/cre2.131, PMID 30386642.

Sanekata T, Fukuda T, Miura T, Morino H, Lee C, Maeda K. Evaluation of the antiviral activity of chlorine dioxide and sodium hypochlorite against feline calicivirus, human influenza virus, measles virus, canine distemper virus, human herpesvirus, human adenovirus, canine adenovirus and canine parvovirus. Biocontrol Sci. 2010;15(2):45-9. doi: 10.4265/bio.15.45, PMID 20616431.

Taga T, Tomizawa D, Takahashi H, Adachi S. Acute myeloid leukemia in children: current status and future directions. Pediatr Int. 2016;58(2):71-80. doi: 10.1111/ped.12865, PMID 26645706.

Cammarata Scalisi F, Girardi K, Strocchio L, Merli P, Garret Bernardin AG, Galeotti A. Oral manifestations and complications in childhood acute myeloid leukemia. Cancers (Basel). 2020;12(6):1-11. doi: 10.3390/cancers12061634, PMID 32575613.

Zimmermann C, Meurer MI, Grando LJ, Gonzaga Del Moral JA, Da Silva Rath IB, Schaefer Tavares S. Dental treatment in patients with leukemia. J Oncol. 2015;2015:571739. doi: 10.1155/2015/571739, PMID 25784937.

Misirlioglu M, Adisen MZ, Yilmaz S. Diagnosis of acute myeloid leukemia in a dental hospital: report of a case with severe gingival hypertrophy. Niger J Clin Pract. 2015;18(4):573-6. doi: 10.4103/1119-3077.151803, PMID 25966736.

Fernandes KS, Gallottini M, Castro T, Amato MF, Lago JS, Braz Silva PH. Gingival leukemic infiltration as the first manifestation of acute myeloid leukemia. Spec Care Dentist. 2018;38(3):160-2. doi: 10.1111/scd.12283, PMID 29645289.

Lopez Garcia B, Lee PHA, Yamasaki K, Gallo RL. Anti-fungal activity of cathelicidins and their potential role in candida albicans skin infection. J Invest Dermatol. 2005;125(1):108-15. doi: 10.1111/j.0022-202X.2005.23713.x.

Bertoli S, Paubelle E, Berard E, Saland E, Thomas X, Tavitian S. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. Eur J Haematol. 2019;102(2):131-42. doi: 10.1111/ejh.13183, PMID 30325535.

Recher C. Clinical implications of inflammation in acute myeloid leukemia. Front Oncol. 2021;11:623952. doi: 10.3389/fonc.2021.623952, PMID 33692956.

Francisconi CF, Caldas RJ, Oliveira Martins LJ, Fischer Rubira CM, da Silva Santos PS. Leukemic oral manifestations and their management. Asian Pac J Cancer Prev. 2016;17(3):911-5. doi: 10.7314/APJCP.2016.17.3.911, PMID 27039811.

Li Y, Yang W, Wang W, Lin D, Wei H, Wang Y. Auer rods in mixed phenotype acute leukemia, T/myeloid: a report of three cases. Leuk Res Rep. 2021;15:100236. doi: 10.1016/j.lrr.2021.100236. PMID 33665079.

Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15. doi: 10.1186/s12245-017-0141-z, PMID 28405953.

Pines JM, Poarch K, Hughes S. Recognition and differential diagnosis of hereditary angioedema in the emergency department. J Emerg Med. 2021;60(1):35-43. doi: 10.1016/j.jemermed.2020.09.044, PMID 33218838.

Kaplan AP. Chronic urticaria and angioedema. N Engl J Med. 2002;346(3):175-9. doi: 10.1056/NEJMcp011186.

Karaoren GY, Tomruk SG, Kuseyrioglu I, Kahraman S, Keskin S, Bakan N. Chemotherapy-related angioedema. Turk J Anaesthesiol Reanim. 2015;43(6):442-3. doi: 10.5152/TJAR.2015.46330, PMID 27366546.

Tachdjian R, Johnston DT. Angioedema: differential diagnosis and acute management. Postgrad Med. 2021;133(7):765-70. doi: 10.1080/00325481.2021.1945219, PMID 34134576.

Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003;3(3):311-7. doi: 10.1016/S1567-5769(02)00162-5, PMID 12639808.

Nussberger J, Cugno M, Cicardi M, Agostoni A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol. 1999;104(6):1321-2. doi: 10.1016/s0091-6749(99)70030-8, PMID 10589018.

Obtułowicz K. Bradykinin-mediated angioedema. Pol Arch Med Wewn. 2016;126(1-2):76-85. doi: 10.20452/pamw.3273, PMID 26842379.

Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842-56. doi: 10.1111/j.1398-9995.2007.01427.x, PMID 17620062.

Meotti FC, Campos R, Silva K, Paszcuk AF, Costa R. Inflammatory muscle pain is dependent on the activation of kinin B 1 and B 2 receptors and intracellular kinase. Br J Pharmacol. 2012;6:x. doi: 10.1111/j.1476-5381.2012.01830.

Marceau F, Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov. 2004;3(10):845-52. doi: 10.1038/nrd1522, PMID 15459675.

Shariat MADAr Z, Mahdi F, Warnock M, Homeister JW, Srikanth S, Krijanovski Y. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood. 2006;108(1):192-9. doi: 10.1182/blood-2006-01-0094, PMID 16514058.

Bal C, Baumgartner R, Gompelmann D, Idzko M. Angioedema as a predominant symptom of Bordetella pertussis infection. BMJ Case Rep. 2021;14(3):14-7. doi: 10.1136/bcr-2020-239243, PMID 33653842.

Kalaskar AR. Management of chemotherapy-induced dysgeusia: an important step towards nutritional rehabilitation. Int J Phys Med Rehabil. 2014;02(3). doi: 10.4172/2329-9096.1000198.

Taiyeb Ali T, Abdulla MA, Hashim F. Antibacterial effect of chlorine dioxide and hyaluronate on dental biofilm. Al-bayaty F. Afr J Microbiol Res. 2010;4:1525-31.

Ison A, Odeh IN, Margerum DW. Kinetics and mechanisms of chlorine dioxide and chlorite oxidations of cysteine and glutathione. Inorg Chem. 2006;45(21):8768-75. doi: 10.1021/ic0609554, PMID 17029389.

Pullar JM, Vissers MCM, Winterbourn CC. Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life. 2000;50(4-5):259-66. doi: 10.1080/713803731, PMID 11327319.

Inc CS. Available from: https://www.clordisys.com/whatcd. PHP; 2014.

O Young R. Chlorine dioxide (CLO2) as a non-toxic antimicrobial agent for virus, bacteria and yeast (Candida Albicans). IJVV 2016;2(6). doi: 10.15406/ijvv.2016.02.00052.

##submissions.published##

18-12-2023

##issue.issue##

Vol 15, Special Issue 2 (Dec), 2023

##section.section##

Original Article(s)

##submission.copyrightStatement##

##submission.license.cc.by4.footer##